NLRP3 and cancer: Moreover, in a mice model, NLRP3 deletion inhibited lung tumorigenesis by reducing the levels of IL-1β, whereas its activation upregulated signaling pathways like PI3K-AKT, Erk1/2, and STAT3, which altogether contributed to increased proliferation and cancer metastasis.